Open Government Canada
Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies
Published by Health Canada | Santé Canada
About this dataset
To provide sponsors of new drug submissions with the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug Regulations (Regulations) with respect to comparative bioavailability studies used in support of the safety and efficacy of a drug.